FDA panelists with ties to industry vital in getting Cox-2 drugs back on market

WASHINGTON (AP) - Ten members of the U.S. Food and Drug Administration advisory panel who voted that a group of powerful pain killers should continue to be sold had ties to the drugs makers, a new analysis shows....More